Immunogenicity of the pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) administered concomitantly with the meningococcal serogroup B (4CMenB) vaccine in infants: A post-hoc analysis in a phase 3b, randomised, controlled trial.
Sign Up to like & getrecommendations! Published in 2019 at "Vaccine"
DOI: 10.1016/j.vaccine.2019.07.021
Abstract: BACKGROUND No data are currently available on immunogenicity of higher-valent pneumococcal conjugate vaccines when co-administered with a 4-component meningococcal serogroup B vaccine (4CMenB). METHODS Post-hoc analysis of pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine… read more here.
Keywords: post hoc; immunogenicity; conjugate; meningococcal serogroup ... See more keywords
Economic evaluation of meningococcal serogroup B (MenB) vaccines: A systematic review.
Sign Up to like & getrecommendations! Published in 2021 at "Vaccine"
DOI: 10.1016/j.vaccine.2021.02.049
Abstract: BACKGROUND Meningococcal serogroup B (MenB) has emerged as the leading cause of invasive meningococcal disease (IMD) in several countries following the release of effective vaccines against serogroups A, C, W, and Y. In 2013, however,… read more here.
Keywords: menb; meningococcal serogroup; serogroup menb; menb vaccines ... See more keywords
Clinically proven specification setting for a meningococcal serogroup a conjugate vaccine.
Sign Up to like & getrecommendations! Published in 2022 at "Vaccine"
DOI: 10.1016/j.vaccine.2022.04.053
Abstract: GSK is currently working to improve the commercial presentation of the licensed quadrivalent conjugate vaccine (Menveo) for use against meningococcal serogroup A, C, W, Y (MenACWY) infections. Menveo consists of a primary, lyophilized vial, containing… read more here.
Keywords: meningococcal serogroup; vaccine; conjugate vaccine; serogroup ... See more keywords
Serum Bactericidal Antibody Responses of Students Immunized With a Meningococcal Serogroup B Vaccine in Response to an Outbreak on a University Campus
Sign Up to like & getrecommendations! Published in 2017 at "Clinical Infectious Diseases"
DOI: 10.1093/cid/cix519
Abstract: Background MenB-4C is a recently licensed meningococcal serogroup B vaccine. For vaccine licensure, short-term efficacy was inferred from serum bactericidal antibody (SBA) titers against 3 antigen-specific indicator strains, which are not necessarily representative of US… read more here.
Keywords: meningococcal serogroup; campus; university; vaccine ... See more keywords
Urticarial vasculitis after meningococcal serogroup B vaccine in a 6‐year‐old girl
Sign Up to like & getrecommendations! Published in 2018 at "Pediatric Dermatology"
DOI: 10.1111/pde.13339
Abstract: The first vaccine that shows significant potential in providing broad coverage against serogroup B meningococcal disease has recently been approved. Because of its newness, potential adverse events need to be reported. Here we report a… read more here.
Keywords: meningococcal serogroup; vasculitis meningococcal; serogroup vaccine; vaccine ... See more keywords
Health workers’ perceptions and challenges in implementing meningococcal serogroup a conjugate vaccine in the routine childhood immunization schedule in Burkina Faso
Sign Up to like & getrecommendations! Published in 2020 at "BMC Public Health"
DOI: 10.1186/s12889-020-8347-z
Abstract: Background Meningococcal serogroup A conjugate vaccine (MACV) was introduced in 2017 into the routine childhood immunization schedule (at 15–18 months of age) in Burkina Faso to help reduce meningococcal meningitis burden. MACV was scheduled to be… read more here.
Keywords: burkina faso; vaccine; meningococcal serogroup; health workers ... See more keywords
Induction of salivary antibody levels in Dutch adolescents after immunization with monovalent meningococcal serogroup C or quadrivalent meningococcal serogroup A, C, W and Y conjugate vaccine
Sign Up to like & getrecommendations! Published in 2018 at "PLoS ONE"
DOI: 10.1371/journal.pone.0191261
Abstract: Background Meningococcal infection starts with colonisation of the upper respiratory tract. Mucosal immunity is important for protection against acquisition and subsequent meningococcal carriage. In this study, we assessed salivary antibody levels against meningococcal serogroup A… read more here.
Keywords: meningococcal serogroup; salivary antibody; serogroup; vaccination ... See more keywords
Meningococcal Serogroup B Vaccine Immunogenicity in High-Risk Groups: What Are the Implications?
Sign Up to like & getrecommendations! Published in 2018 at "Pediatrics"
DOI: 10.1542/peds.2018-0554
Abstract: * Abbreviation: 4CMenB — : component Meningococcal B Vaccine (Bexsero) quadrivalent Neisseria meningitidis is an organism that is well-known to pediatricians as an important cause of sepsis, which can be fulminant, and of bacterial meningitis… read more here.
Keywords: vaccine immunogenicity; immunogenicity high; meningococcal serogroup; high risk ... See more keywords
Evaluation of Meningococcal Serogroup C Bactericidal Antibodies after Primary Vaccination: A Multicentre Study, Italy
Sign Up to like & getrecommendations! Published in 2022 at "Vaccines"
DOI: 10.3390/vaccines10050778
Abstract: Here, we evaluated over time in different cohorts of children vaccinated against serogroup C Neisseria meningitidis, the presence of antibodies with neutralizing activity. A total of 348 sera samples of enrolled children by year since… read more here.
Keywords: year; serogroup; vaccination; bactericidal antibodies ... See more keywords